De novo lipogenesis in metabolic homeostasis: More friend than foe?

Molecular Metabolism

Volumn 4, Issue 5, 2015, Pages 367-377

  Solinas, Giovanni ^a   Borén, Jan ^a   Dulloo, Abdul G ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Ectopic lipids; Glucose disposal; Lipokines; Metabolic flexibility; Obesity; Thermogenesis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; FATTY ACID SYNTHASE;

ADIPOSE TISSUE; CALORIC INTAKE; CALORIC RESTRICTION; COLD; DE NOVO LIPOGENESIS; ENERGY BALANCE; ENERGY COST; ENERGY EXPENDITURE; ENZYME INACTIVATION; FATTY LIVER; GLUCONEOGENESIS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; LEAN BODY WEIGHT; LIPID STORAGE; LIPOGENESIS; LIPOTOXICITY; METABOLIC REGULATION; METABOLIC STRESS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 84933678172     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.03.004     Document Type: Review

References (105)

1. Dombrowski S.U., Knittle K., Avenell A., Araujo-Soares V., Sniehotta F.F. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. British Medical Journal 2014, 348:g2646.
2. Unger R.H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003, 144:5159-5165.
3. Unger R.H., Clark G.O., Scherer P.E., Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 2010, 1801:209-214.
4. Thiam A.R., Farese R.V., Walther T.C. The biophysics and cell biology of lipid droplets. Nature Reviews Molecular Cell Biology 2013, 14:775-786.
5. Solinas G. Molecular pathways linking metabolic inflammation and thermogenesis. Obesity Reviews 2012, 13(Suppl.2):69-82.
6. Virtue S., Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biology 2008, 6:e237.
7. Solinas G., Karin M. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB Journal 2010, 24:2596-2611.
8. Jacome-Sosa M.M., Parks E.J. Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Current Opinion In Lipidology 2014, 25:213-220.
9. Ameer F., Scandiuzzi L., Hasnain S., Kalbacher H., Zaidi N. De novo lipogenesis in health and disease. Metabolism 2014, 63:895-902.
10. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Journal of Clinical Investigation 2005, 115:1343-1351.
11. Lambert J.E., Ramos-Roman M.A., Browning J.D., Parks E.J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 2014, 146:726-735.
12. Kirk E., Reeds D.N., Finck B.N., Mayurranjan S.M., Patterson B.W., Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009, 136:1552-1560.
13. Haufe S., Engeli S., Kast P., Bohnke J., Utz W., Haas V., et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011, 53:1504-1514.
14. Sobrecases H., Le K.A., Bortolotti M., Schneiter P., Ith M., Kreis R., et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes & Metabolism 2010, 36:244-246.
15. Faeh D., William J., Tappy L., Ravussin E., Bovet P. Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health 2007, 7:163.
16. Thorbek G., Chwalibog A., Henckel S. Energetics of growth in pigs from 20 to 120 kg live weight. ZTierphysiol Tierernahr Futtermittelkd 1983, 49:238-249.
17. Chwalibog A., Thorbek G. Energy expenditure by de novo lipogenesis. British Journal of Nutrition 2001, 86:309.
18. Horton T.J., Drougas H., Brachey A., Reed G.W., Peters J.C., Hill J.O. Fat and carbohydrate overfeeding in humans: different effects on energy storage. American Journal of Clinical Nutrition 1995, 62:19-29.
19. Marques-Lopes I., Ansorena D., Astiasaran I., Forga L., Martinez J.A. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. American Journal of Clinical Nutrition 2001, 73:253-261.
20. Minehira K., Bettschart V., Vidal H., Vega N., Di Vetta V., Rey V., et al. Effect of carbohydrate overfeeding on whole body and adipose tissue metabolism in humans. Obesity Research 2003, 11:1096-1103.
21. Dirlewanger M., di Vetta V., Guenat E., Battilana P., Seematter G., Schneiter P., et al. Effects of short-term carbohydrate or fat overfeeding on energy expenditure and plasma leptin concentrations in healthy female subjects. International Journal of Obesity and Related Metabolic Disorders 2000, 24:1413-1418.
22. Letexier D., Pinteur C., Large V., Frering V., Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. Journal of Lipid Research 2003, 44:2127-2134.
23. Strawford A., Antelo F., Christiansen M., Hellerstein M.K. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. American Journal of Physiology. Endocrinology and Metabolism 2004, 286:E577-E588.
24. Minehira K., Vega N., Vidal H., Acheson K., Tappy L. Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. International Journal of Obesity and Related Metabolic Disorders 2004, 28:1291-1298.
25. Aarsland A., Chinkes D., Wolfe R.R. Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. American Journal of Clinical Nutrition 1997, 65:1774-1782.
26. Salans L.B., Knittle J.L., Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. Journal of Clinical Investigation 1968, 47:153-165.
27. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
28. Roberts R., Hodson L., Dennis A.L., Neville M.J., Humphreys S.M., Harnden K.E., et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52:882-890.
29. Diraison F., Dusserre E., Vidal H., Sothier M., Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. American Journal of Physiology. Endocrinology and Metabolism 2002, 282:E46-E51.
30. Eissing L., Scherer T., Todter K., Knippschild U., Greve J.W., Buurman W.A., et al. De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health. Nature Communications 2013, 4:1528.
31. Beigneux A.P., Kosinski C., Gavino B., Horton J.D., Skarnes W.C., Young S.G. ATP-citrate lyase deficiency in the mouse. Journal of Biological Chemistry 2004, 279:9557-9564.
32. Wang Q., Jiang L., Wang J., Li S., Yu Y., You J., et al. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology 2009, 49:1166-1175.
33. Hems D.A., Rath E.A., Verrinder T.R. Fatty acid synthesis in liver and adipose tissue of normal and genetically obese (ob/ob) mice during the 24-hour cycle. Biochemical Journal 1975, 150:167-173.
34. Fruhbeck G., Aguado M., Martinez J.A. Invitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochemical and Biophysical Research 1997, 240:590-594.
35. Fruhbeck G., Aguado M., Gomez-Ambrosi J., Martinez J.A. Lipolytic effect of invivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochemical and Biophysical Research 1998, 250:99-102.
36. Wang Q., Li S., Jiang L., Zhou Y., Li Z., Shao M., et al. Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice. Journal of Lipid Research 2010, 51:2516-2526.
37. Abu-Elheiga L., Matzuk M.M., Kordari P., Oh W., Shaikenov T., Gu Z., et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12011-12016.
38. Mao J., DeMayo F.J., Li H., Abu-Elheiga L., Gu Z., Shaikenov T.E., et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:8552-8557.
39. Abu-Elheiga L., Matzuk M.M., Abo-Hashema K.A., Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001, 291:2613-2616.
40. Abu-Elheiga L., Oh W., Kordari P., Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:10207-10212.
41. Olson D.P., Pulinilkunnil T., Cline G.W., Shulman G.I., Lowell B.B. Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7598-7603.
42. Hoehn K.L., Turner N., Swarbrick M.M., Wilks D., Preston E., Phua Y., et al. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metabolism 2010, 11:70-76.
43. Savage D.B., Choi C.S., Samuel V.T., Liu Z.X., Zhang D., Wang A., et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. Journal of Clinical Investigation 2006, 116:817-824.
44. Trayhurn P. Fatty acid synthesis in mouse brown adipose tissue. The influence of environmental temperature on the proportion of whole-body fatty acid synthesis in brown adipose tissue and the liver. Biochimica et Biophysica Acta 1981, 664:549-560.
45. Yu X.X., Lewin D.A., Forrest W., Adams S.H. Cold elicits the simultaneous induction of fatty acid synthesis and beta-oxidation in murine brown adipose tissue: prediction from differential gene expression and confirmation invivo. FASEB Journal 2002, 16:155-168.
46. Solinas G., Summermatter S., Mainieri D., Gubler M., Montani J.P., Seydoux J., et al. Corticotropin-releasing hormone directly stimulates thermogenesis in skeletal muscle possibly through substrate cycling between de novo lipogenesis and lipid oxidation. Endocrinology 2006, 147:31-38.
47. Dulloo A.G., Gubler M., Montani J.P., Seydoux J., Solinas G. Substrate cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity. International Journal of Obesity and Related Metabolic Disorders 2004, 28(Suppl 4):S29-S37.
48. Solinas G., Summermatter S., Mainieri D., Gubler M., Pirola L., Wymann M.P., et al. The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Letters 2004, 577:539-544.
49. Mottillo E.P., Balasubramanian P., Lee Y.H., Weng C., Kershaw E.E., Granneman J.G. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic beta3-adrenergic receptor activation. Journal of Lipid Research 2014, 55:2276-2286.
50. Chow J.D., Lawrence R.T., Healy M.E., Dominy J.E., Liao J.A., Breen D.S., et al. Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation. Molecular Metabolism 2014, 3:419-431.
51. O'Sullivan D., van der Windt G.J., Huang S.C., Curtis J.D., Chang C.H., Buck M.D., et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 2014, 41:75-88.
52. Wu M., Singh S.B., Wang J., Chung C.C., Salituro G., Karanam B.V., et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:5378-5383.
53. Chirala S.S., Chang H., Matzuk M., Abu-Elheiga L., Mao J., Mahon K., et al. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6358-6363.
54. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metabolism 2005, 1:309-322.
55. Chakravarthy M.V., Lodhi I.J., Yin L., Malapaka R.R., Xu H.E., Turk J., et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009, 138:476-488.
56. Chakravarthy M.V., Zhu Y., Lopez M., Yin L., Wozniak D.F., Coleman T., et al. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. Journal of Clinical Investigation 2007, 117:2539-2552.
57. Schneider J.G., Yang Z., Chakravarthy M.V., Lodhi I.J., Wei X., Turk J., et al. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. Journal of Biological Chemistry 2010, 285:23398-23409.
58. Lodhi I.J., Yin L., Jensen-Urstad A.P., Funai K., Coleman T., Baird J.H., et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metabolism 2012, 16:189-201.
59. Wei X., Schneider J.G., Shenouda S.M., Lee A., Towler D.A., Chakravarthy M.V., et al. De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. Journal of Biological Chemistry 2011, 286:2933-2945.
60. Wei X., Yang Z., Rey F.E., Ridaura V.K., Davidson N.O., Gordon J.I., et al. Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe 2012, 11:140-152.
61. Funai K., Song H., Yin L., Lodhi I.J., Wei X., Yoshino J., et al. Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling. Journal of Clinical Investigation 2013, 123:1229-1240.
62. Razani B., Zhang H., Schulze P.C., Schilling J.D., Verbsky J., Lodhi I.J., et al. Fatty acid synthase modulates homeostatic responses to myocardial stress. Journal of Biological Chemistry 2011, 286:30949-30961.
63. Fabrizi M., Marchetti V., Mavilio M., Marino A., Casagrande V., Cavalera M., et al. IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity. Diabetes 2014, 63:2086-2096.
64. Eguchi J., Wang X., Yu S., Kershaw E.E., Chiu P.C., Dushay J., et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metabolism 2011, 13:249-259.
65. Perino A., Beretta M., Kilic A., Ghigo A., Carnevale D., Repetto I.E., et al. Combined inhibition of PI3Kbeta and PI3Kgamma reduces fat mass by enhancing alpha-MSH-dependent sympathetic drive. Science Signalling 2014, 7:ra110.
66. Becattini B., Marone R., Zani F., Arsenijevic D., Seydoux J., Montani J.P., et al. PI3Kgamma within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E854-E863.
67. Schreiber R., Zechner R. Lipolysis meets inflammation: arachidonic acid mobilization from fat. Journal of Lipid Research 2014, 55:2447-2449.
68. Dichlberger A., Schlager S., Maaninka K., Schneider W.J., Kovanen P.T. Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells. Journal of Lipid Research 2014, 55:2471-2478.
69. Chakravarthy M.V., Zhu Y., Yin L., Coleman T., Pappan K.L., Marshall C.A., et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. Journal of Lipid Research 2009, 50:630-640.
70. Galvan-Pena S., O'Neill L.A. Metabolic reprograming in macrophage polarization. Front Immunol 2014, 5:420.
71. Infantino V., Iacobazzi V., Menga A., Avantaggiati M.L., Palmieri F. Akey role of the mitochondrial citrate carrier (SLC25A1) in TNFalpha- and IFNgamma-triggered inflammation. Biochimica et Biophysica Acta 2014, 1839:1217-1225.
72. Infantino V., Iacobazzi V., Palmieri F., Menga A. ATP-citrate lyase is essential for macrophage inflammatory response. Biochemical and Biophysical Research 2013, 440:105-111.
73. Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., et al. The mitochondrial citrate carrier: a new player in inflammation. Biochemical Journal 2011, 438:433-436.
74. Dufort F.J., Gumina M.R., Ta N.L., Tao Y., Heyse S.A., Scott D.A., et al. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. Journal of Biological Chemistry 2014, 289:7011-7024.
75. Fox C.J., Hammerman P.S., Thompson C.B. Fuel feeds function: energy metabolism and the T-cell response. Nature Reviews Immunology 2005, 5:844-852.
76. Matsuo S., Yang W.L., Aziz M., Kameoka S., Wang P. Fatty acid synthase inhibitor C75 ameliorates experimental colitis. Molecular Medicine 2014, 20:1-9.
77. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409:729-733.
78. Kotani K., Peroni O.D., Minokoshi Y., Boss O., Kahn B.B. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. Journal of Clinical Investigation 2004, 114:1666-1675.
79. Carvalho E., Kotani K., Peroni O.D., Kahn B.B. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. American Journal of Physiology. Endocrinology and Metabolism 2005, 289:E551-E561.
80. Herman M.A., Peroni O.D., Villoria J., Schon M.R., Abumrad N.A., Bluher M., et al. Anovel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012, 484:333-338.
81. Kuriyama H., Liang G., Engelking L.J., Horton J.D., Goldstein J.L., Brown M.S. Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver. Cell Metabolism 2005, 1:41-51.
82. Beaven S.W., Matveyenko A., Wroblewski K., Chao L., Wilpitz D., Hsu T.W., et al. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance. Cell Metabolism 2013, 18:106-117.
83. Yore M.M., Syed I., Moraes-Vieira P.M., Zhang T., Herman M.A., Homan E.A., et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 2014, 159:318-332.
84. Cao H., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134:933-944.
85. Galgani J.E., Moro C., Ravussin E. Metabolic flexibility and insulin resistance. American Journal of Physiology. Endocrinology and Metabolism 2008, 295:E1009-E1017.
86. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
87. Shimano H., Shimomura I., Hammer R.E., Herz J., Goldstein J.L., Brown M.S., et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. Journal of Clinical Investigation 1997, 100:2115-2124.
88. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 1:785-789.
89. Randle P.J., Garland P.B., Newsholme E.A., Hales C.N. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Annals of the New York Academy of Sciences 1965, 131:324-333.
90. Chavez J.A., Summers S.A. Aceramide-centric view of insulin resistance. Cell Metabolism 2012, 15:585-594.
91. Perry R.J., Samuel V.T., Petersen K.F., Shulman G.I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014, 510:84-91.
92. Bruss M.D., Khambatta C.F., Ruby M.A., Aggarwal I., Hellerstein M.K. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. American Journal of Physiology. Endocrinology and Metabolism 2010, 298:E108-E116.
93. Crescenzo R., Samec S., Antic V., Rohner-Jeanrenaud F., Seydoux J., Montani J.P., et al. Arole for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes 2003, 52:1090-1097.
94. Cettour-Rose P., Samec S., Russell A.P., Summermatter S., Mainieri D., Carrillo-Theander C., et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 2005, 54:751-756.
95. Summermatter S., Mainieri D., Russell A.P., Seydoux J., Montani J.P., Buchala A., et al. Thrifty metabolism that favors fat storage after caloric restriction: a role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase. FASEB Journal 2008, 22:774-785.
96. Summermatter S., Marcelino H., Arsenijevic D., Buchala A., Aprikian O., Assimacopoulos-Jeannet F., et al. Adipose tissue plasticity during catch-up fat driven by thrifty metabolism: relevance for muscle-adipose glucose redistribution during catch-up growth. Diabetes 2009, 58:2228-2237.
97. Marcelino H., Veyrat-Durebex C., Summermatter S., Sarafian D., Miles-Chan J., Arsenijevic D., et al. Arole for adipose tissue de novo lipogenesis in glucose homeostasis during catch-up growth: a Randle cycle favoring fat storage. Diabetes 2013, 62:362-372.
98. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 2000, 404:652-660.
99. Rothwell N.J., Stock M.J. Arole for brown adipose tissue in diet-induced thermogenesis. Nature 1979, 281:31-35.
100. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB Journal 2009, 23:3113-3120.
101. Vollmers C., Gill S., DiTacchio L., Pulivarthy S.R., Le H.D., Panda S. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:21453-21458.
102. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine 2009, 360:1500-1508.
103. Masoro E.J. Role of lipogenesis in nonshivering thermogenesis. Federation Proceedings 1963, 22:868-873.
104. de Jesus L.A., Carvalho S.D., Ribeiro M.O., Schneider M., Kim S.W., Harney J.W., et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. Journal of Clinical Investigation 2001, 108:1379-1385.
105. Christoffolete M.A., Linardi C.C., de Jesus L., Ebina K.N., Carvalho S.D., Ribeiro M.O., et al. Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 2004, 53:577-584.